Sensus Healthcare
SRTS
17 hedge funds and large institutions have $10.2M invested in Sensus Healthcare in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
6% more funds holding
Funds holding: 16 → 17 (+1)
5% more capital invested
Capital invested by funds: $9.76M → $10.2M (+$443K)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.51% less ownership
Funds ownership: 10.81% → 10.31% (-0.51%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$523K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$19.4K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$12.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.5K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$341K |
| 2 |
GBA
Garrison Bradford & Associates
New York
|
-$233K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$180K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$152K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$30.7K |
SRTS Hedge Fund Activity: Q3 2019 in Review
17 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q3 2019, worth a combined $10.2M — up 4.5% from $9.76M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SRTS positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $523K. The largest seller was Perkins Capital Management, cutting an estimated $341K.
- 17 institutional investors held Sensus Healthcare (SRTS) as of Q3 2019, up from 16 in Q2 2019.
- Funds reported $10.2M of Sensus Healthcare stock for Q3 2019, up 4.5% quarter-over-quarter.
- 3 funds opened new Sensus Healthcare positions in Q3 2019 and 2 closed out, a net change of +1 holder.
- The largest Sensus Healthcare buyer in Q3 2019 was Essex Investment Management, an estimated $523K added.
- The largest Sensus Healthcare seller in Q3 2019 was Perkins Capital Management, an estimated $341K sold.
Based on aggregated 13F filings for Q3 2019.